Unicamp researchers discovered that counterfeit weight-loss injections manufactured in Paraguay and marketed as tirzepatida (the active ingredient in Mounjaro) do contain the authentic pharmaceutical substance, revealing a significant cross-border drug trafficking and falsification scheme. The findings underscore risks associated with unregulated production and highlight a broader issue of illegal pharmaceutical commerce targeting popular obesity-treatment drugs.